Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 23-Apr-2014
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 21)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
23-Apr-14Pechala's ReportsLubomir PechalaAKORN INC (AKRX) - REPORT FOR ACTIVE TRADERS1$25  View Abstract
23-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-generic Drugs17$49  View Abstract
19-Apr-14Pechala's ReportsFrantisek PechalaAKORN INC (AKRX) 12-months forecast1$15  View Abstract
18-Apr-14Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of AKORN INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20  View Abstract
17-Apr-14ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for AKRX11$25  View Abstract
17-Apr-14Ford Investor Services, Inc.N/AIndustry Value Graph: ACRX , AKRX , ALIM , AOBID , AVNR , DYAX , SCLN , SCMP -- DRUGS3$34.50  View Abstract
17-Apr-14Ford Investor Services, Inc.N/AValue Graph: AKORN -- AKRX1$11.50  View Abstract
16-Apr-14Zacks Investment Research Inc.N/AAKORN INC (AKRX) Zacks Company Snapshot1$11.50  View Abstract
15-Apr-14Zacks Investment Research Inc.N/AAKORN INC (AKRX) Zacks Company Snapshot1$11.50  View Abstract
13-Apr-14TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: AKORN INC (AKRX)5$10  View Abstract
Next 11

Independent Reports (Showing 1 to 10 of 21)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
23-Apr-14Pechala's ReportsLubomir PechalaAKORN INC (AKRX) - REPORT FOR ACTIVE TRADERS1$25View Abstract
23-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-generic Drugs17$49View Abstract
19-Apr-14Pechala's ReportsFrantisek PechalaAKORN INC (AKRX) 12-months forecast1$15View Abstract
18-Apr-14Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of AKORN INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20View Abstract
17-Apr-14ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for AKRX11$25View Abstract
17-Apr-14Ford Investor Services, Inc.N/AIndustry Value Graph: ACRX , AKRX , ALIM , AOBID , AVNR , DYAX , SCLN , SCMP -- DRUGS3$34.50View Abstract
17-Apr-14Ford Investor Services, Inc.N/AValue Graph: AKORN -- AKRX1$11.50View Abstract
16-Apr-14Zacks Investment Research Inc.N/AAKORN INC (AKRX) Zacks Company Snapshot1$11.50View Abstract
15-Apr-14Zacks Investment Research Inc.N/AAKORN INC (AKRX) Zacks Company Snapshot1$11.50View Abstract
13-Apr-14TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: AKORN INC (AKRX)5$10View Abstract
Next 11

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.